These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17659946)

  • 1. Effects of once weekly rosuvastatin among patients with a prior statin intolerance.
    Backes JM; Moriarty PM; Ruisinger JF; Gibson CA
    Am J Cardiol; 2007 Aug; 100(3):554-5. PubMed ID: 17659946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
    Mackie BD; Satija S; Nell C; Miller J; Sperling LS
    Am J Cardiol; 2007 Jan; 99(2):291. PubMed ID: 17223437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance.
    Ruisinger JF; Backes JM; Gibson CA; Moriarty PM
    Am J Cardiol; 2009 Feb; 103(3):393-4. PubMed ID: 19166695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.
    Kennedy SP; Barnas GP; Schmidt MJ; Glisczinski MS; Paniagua AC
    J Clin Lipidol; 2011; 5(4):308-15. PubMed ID: 21784377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rosuvastatin every other day compared with once daily in patients with hypercholesterolemia.
    Wongwiwatthananukit S; Sansanayudh N; Dhummauppakorn R; Kitiyadisai C
    Ann Pharmacother; 2006 Nov; 40(11):1917-23. PubMed ID: 17003082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.
    Gadarla M; Kearns AK; Thompson PD
    Am J Cardiol; 2008 Jun; 101(12):1747-8. PubMed ID: 18549851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: a case report and literature review.
    Gopalagowda BH; Cutchins C; Cutchins DC; Peiris AN
    Tenn Med; 2011 Feb; 104(2):49-51. PubMed ID: 21387899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
    Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
    Stein EA; Amerena J; Ballantyne CM; Brice E; Farnier M; Guthrie RM; Harats D; Ma PT; Le Maulf F; Melezínková H; Gold A; Sager P
    Am J Cardiol; 2007 Nov; 100(9):1387-96. PubMed ID: 17950795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
    Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F;
    Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of rosuvastatin.
    Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
    Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.
    van der Lee M; Sankatsing R; Schippers E; Vogel M; Fätkenheuer G; van der Ven A; Kroon F; Rockstroh J; Wyen C; Bäumer A; de Groot E; Koopmans P; Stroes E; Reiss P; Burger D
    Antivir Ther; 2007; 12(7):1127-32. PubMed ID: 18018771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding options with a wider range of rosuvastatin doses.
    Olsson AG
    Clin Ther; 2006 Nov; 28(11):1747-63. PubMed ID: 17212997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
    Kjekshus J; Dunselman P; Blideskog M; Eskilson C; Hjalmarson A; McMurray JV; Waagstein F; Wedel H; Wessman P; Wikstrand J;
    Eur J Heart Fail; 2005 Oct; 7(6):1059-69. PubMed ID: 16227145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers.
    Li JJ; Yang P; Liu J; Jia YJ; Li ZC; Guo YL; Wu NQ; Tang YD; Jiang LX
    Clin Chim Acta; 2012 Jan; 413(1-2):139-42. PubMed ID: 21983163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and plasma drug concentrations with nondaily dosing of rosuvastatin.
    Goldberg AS; DeGorter MK; Ban MR; Kim RB; Hegele RA
    Can J Cardiol; 2013 Aug; 29(8):915-9. PubMed ID: 23465343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.